CDRH Vision - Total Product Life Cycle - PowerPoint PPT Presentation

1 / 41
About This Presentation
Title:

CDRH Vision - Total Product Life Cycle

Description:

Click to edit Master subtitle style. CDRH Vision - Total Product ... The callback writing session mean = 4.7. No Use. Essential. CDRH Science Review Evaluation ... – PowerPoint PPT presentation

Number of Views:62
Avg rating:3.0/5.0
Slides: 42
Provided by: davidwill6
Learn more at: https://www.fda.gov
Category:

less

Transcript and Presenter's Notes

Title: CDRH Vision - Total Product Life Cycle


1
(No Transcript)
2
CDRH Vision - Total Product Life Cycle
3
(No Transcript)
4
(No Transcript)
5
CDRH Science Review
  • Planning of Review - Nov 1999
  • Internal Review March 2001
  • External Review
  • June 21, 2001 (Orientation)
  • July 24 to 26, 2001
  • Science Board Report Nov 2001
  • Science Review Implementation

6
Broad Areas of Focus CDRH Internal External
Reviews
  • Review seeks information about the Centers
    decision making process
  • Scientific decision making
  • Impact of decision made by CDRH
  • Resources required
  • Integration of decisions made
  • Processes and feedback mechanisms to document
    decisions and enhance organizational learning
  • Preparedness to address future science issues

7
Internal Review
  • Top 10 list of the greatest challenges and
    problems for science-based regulation at CDRH
  • Top 10 list of recommendations for
    science-based regulation at CDRH

8
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • CDRH is not always recognized as a science-based
    organization by
  • parts of CDRH and FDA,
  • the Department of Health and Human Services,
  • Congress and
  • Industry.
  • Recommendation
  • CDRH needs to communicate its scientific vision
    and the scientific basis for its regulatory
    actions.
  • CDRH needs advocates for its scientific role in
    medical devices and radiological health,
    including the FDA Science Board

9
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • The Center leadership does not always communicate
    science as a priority. We miss opportunities to
    creating the time and resources for our
    scientists to have the training and experiences
    to stay current and build their scientific
    expertise. Budget and resource planning is often
    reactive and short term and not well used to
    walk the talk of the priority of science.
  • Recommendation
  • The Center leadership needs to demonstrate the
    priority of science in how it allocates its human
    resources, and through strategies to maintain and
    build science capacity in the Center.

10
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • CDRHs scientific staff is graying and an
    anticipated wave of retirement will exacerbate
    the shortages of some types of expertise.
    Replacement hiring will also create challenging
    opportunities.
  • Recommendation
  • CDRH needs to implement the Magnet for Excellence
    goal area of its strategic plan which seeks to
    recruit and retain the type of employees that
    will help us accomplish our public health
    mission.

11
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • Budget policies of the last eight years have
    markedly reduced operating dollars leaving
    laboratory programs and information technology
    infrastructure funded at a subsistence level.
  • Recommendation
  • Rich or poor, the Center needs to assure that
    there are enough operating dollars (vs. salary
    dollars) to provide the funds needed to maintain
    the effectiveness of our employees.

12
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • New staff is trained largely by apprenticeship
    with insufficient attention to assuring the
    development of the core competencies needed for
    science-based regulation.
  • Recommendation
  • CDRH needs to identify core competencies and the
    types of experiences that will develop them to
    create a flexible scientific workforce able to
    meet future challenges.

13
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • Premarket deadlines, acute problems, and squeaky
    wheels dominate resource allocation and leave
    programs disconnected and sometimes out of
    balance.
  • Recommendation
  • The Centers strategic vision of assuring the
    public health throughout the total product life
    cycle and having meaningful measures of the
    impact of our efforts are strategies that will
    allow us to prioritize work better by the impact
    that it has.

14
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • Scientific communication opportunities are
    underutilized, whether with scientific peers,
    medical device users or the general public. This
    limits our mission effectiveness.
  • Recommendation
  • The goal area of Knowledge Management in the
    Centers strategic plan provides an approach not
    only to the acquisition and management of new
    knowledge, but also to the dissemination to our
    stakeholders to promote our mission.

15
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • We solve many problems too slowly in a rapidly
    changing world. While decision making is often
    timely, implementation is often not.
  • Recommendation
  • CDRH should set goals, choose important problems,
    assess how to measure impact, create the team
    needed and be accountable for timely results from
    its efforts.

16
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • Peer review is underutilized as a method for
    prioritizing efforts and evaluation. Choices are
    heavily driven by regulatory needs and evaluation
    is usually done through the organizational
    hierarchy.
  • Recommendation
  • Peer review should be routinely incorporated into
    the science-based decision making and
    science-based efforts by peers within and from
    outside the Center to supplement other methods of
    assessing scientific quality and effectiveness.

17
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  • Scientific partnerships with NIH, NAS,
    Universities, professional societies exist, but
    are underdeveloped.
  • Recommendation
  • Scientific partnerships with NIH, NAS,
    Universities, professional societies exist,
    should be developed as a source of external
    expertise, as sources of recruitment, and for
    partnerships in mission related activities.

18
Evaluation of External Review
  • Survey of External Panel Members
  • (11/12 responded)

19
CDRH Science Review Evaluation
No Use
Essential
  1. Opening the scope of the review to include the
    entire Center, i.e., not limited to a laboratory
    science review mean 4.9
  2. The early planning/kick-off meeting in Atlanta
    on June 21, 2001 mean 4.2
  3. Background materials on CDRHs Mission and
    Organization mean 4.5

20
CDRH Science Review Evaluation
No Use
Essential
  • Case Studies - the concept mean 4.1
  • - the materials
  • mean 3.8 - the staff Interviews
  • mean 4.8

21
CDRH Science Review Evaluation
No Use
Essential
  • On the Spot - the concept mean 4.0
  • - the materials
  • mean 2.7 - the staff Interviews
  • mean 4.1

22
CDRH Science Review Evaluation
No Use
Essential
  • Role Playing Sessions mean 3.8
  • The Industry Interviews
  • mean 4.1
  • The callback writing session mean 4.7

23
CDRH Science Review Evaluation
  • Open Ended Questions
  • What was the best/most useful activity or
    component of the Science Review?
  • What was the worst/least useful activity or
    component of the Science Review?
  • Which of the Committees recommendations do you
    believe CDRH must address in the near term to
    address a critical flaw?
  • Which of the Committees recommendations do you
    believe CDRH must address to assure our place
    as a scientific leader in the medical device
    community?

24
What was the best/most useful activity or
component of the Science Review?
  • case studies and industry interviews
  • the thought that preceded the committees work
    allowed more substantive activity as did the
    excellent prepared materials
  • interviews with the management and staff (2)
  • staff interviews all were great essential to
    further our understanding of the issues and way
    CDRH processes information discussion with staff
    and case studies
  • the background materials were essential to
    getting up to speed. The interviews were
    essential to understanding realities of the
    Center beyond the public persona or management
    view
  • staff interviews
  • interfacing with staff
  • discussion of recommendations

25
What was the worst/least useful activity or
component of the Science Review?
  • role playing sessions (2)
  • on the spot was least useful as it was
    difficult for the review team to know what to ask
    for. Not really necessary. Would have been
    better to have more time for discussions with
    CDRH staff
  • preselection of case studies
  • science review committee was too heavily
    weighted towards an industry bias. Insufficient
    federal scientific stakeholder representation
  • it was a bit scripted, and some things slipped
    past before we realized they needed more thoughts
  • on the spot
  • every part was good
  • the on the spot activities were unfocused and
    for more work than was valuable. This time could
    have been better spent.
  • the case studies were good but need to be very
    carefully selected or they are not useful
  • on the spot binder lists of documents not
    helpful
  • on the spot materials
  • trying to understand the materials and cope with
    the quantity

26
Which of the Committees recommendations do you
believe CDRH must address in the near term to
address a critical flaw?
  • all of them
  • manpower distribution
  • workload distribution
  • more transparent communication
  • Strong immediate need to re-evaluate OST
    structure, if OST exists, must change to reflect
    current and future science. Recommendation 3
  • CDRH should consider outsourcing some of its
    review activities,
  • although it was not contained in the committees
    final recommendations, CDRH should consider
    charge back for industry
  • keep current and support staff
  • Rec 13 14 quality metrics and evaluation
  • Assessment of needs (7)
  • develop a strategic staffing plan to accommodate
    expected turnover/attrition/retirement fill
    technical gaps with respect to future
    technologies
  • Develop a plan for cross office communication
    (4)
  • Establish an electrtonic database for decisions
    and inventory (5)
  • Add human factors expertise to panels (10)
  • Funding which drives workload
  • Rec 1 2 define and communicate a vision and
    from that the organization and resources needed
    to meet that vision. Dont start with the
    budget.
  • Position its staff for the next 20 years
    challenge

27
Which of the Committees recommendations do you
believe CDRH must address to assure our place
as a scientific leader in the medical device
community?
  • all of them
  • its difficult, but planned ready enrichment must
    be viewed as a core not supplemental activity
  • staff evaluation is needed to have a clear
    picture or required hiring to maintain (attain)
    expertise needed for biological/technological
    revolution (Rec 7)
  • see Rec 7
  • Be scientific! See Rec 7
  • develop a strategic staffing plan to accommodate
    expected turnover/attrition/retirement fill
    technical gaps with respect to future
    technologies
  • Rec 7 9 expertise of staff
  • Improve career path (
  • More outreach (12) thats the only way to keep
    up and connected
  • Reassess what laboratory programs to support
    some are outdated in other areas critical new
    fields of science are not covered at all
  • Vision is extremely important
  • Identification of those technologies and
    development of an in-house capability in those
    technologies that will support approval of future
    medical devices
  • Add new staff to cope with new technology

28
Science Review Next Steps
  • Establishment of CDRH Recommendations Committee

29
CDRH Science Recommendations Committee
  • Frances Benedict, OCD
  • Bob Cangelosi, OHIP
  • James Dillard, ODE
  • Patricia Dubill, OST
  • Philip Frappaolo, OCD
  • Anita Rayner, OSB
  • Donald Serra, OC
  • Mitchell Shein, ODE
  • Toni Nearing, OCD
  • Kathleen Walker, OSM
  • Cheryll Wells, OC

Representatives from every Office 2 Quality
systems experts
30
Science Review Next Steps
  • Establishment of CDRH Recommendations Committee
  • Scheduling of Division Directors Go-Away to
    address recommendations in light of strategic
    goal areas (Dec 6, 2001)

31
Science Review Next Steps
  • Establishment of CDRH Recommendations Committee
  • Scheduling of Division Directors Go-Away to
    address recommendations in light of strategic
    goal areas (Dec 6, 2001)
  • Internet posting of Final Report
  • www.fda.gov/cdrh/science

32
CDRH Science Review Committee
  • CDRH Recommendations Committee
  • to prioritize the recommendations from the review
    (long and short term priorities), and
  • make suggestions to Sr. Staff on how to merge
    these recommendations into our strategic plan

33
New Technology
Scan Horizon
34
New Technology
Develop Regulatory Path
35
New Technology
Identify External Experts
36
New Technology
Build Internal Capacity
37
New Technology
ConsolidateTPLC Team
38
Center for Devices and Radiological Health
  • Strategic Goal Areas
  • Total Product Life Cycle product management
  • Magnet for Excellence to attract and develop the
    staff to accomplish our mission
  • Knowledge Management
  • Meaningful Metrics

39
Center for Devices and Radiological Health
  • Mission
  • CDRH promotes and protects the health of the
    public by ensuring the safety and effectiveness
    of medical devices and the safety of radiological
    products.

40
Top 10 list of the greatest challenges and
problems for science-based regulation at CDRH
  1. CDRH is not always recognized as a science-based
    organization by parts of CDRH and FDA, the
    Department of Health and Human Services, Congress
    and Industry.
  2. The Center leadership does not always communicate
    science as a priority. We miss opportunities to
    creating the time and resources for our
    scientists to have the training and experiences
    to stay current and build their scientific
    expertise. Budget and resource planning is often
    reactive and short term and not well used to
    walk the talk of the priority of science.
  3. CDRHs scientific staff is graying and an
    anticipated wave of retirement will exacerbate
    the shortages of some types of expertise.
    Replacement hiring will also create challenging
    opportunities.
  4. Budget policies of the last eight years have
    markedly reduced operating dollars leaving
    laboratory programs and information technology
    infrastructure funded at a subsistence level.
  5. New staff is trained largely by apprenticeship
    with insufficient attention to assuring the
    development of the core competencies needed for
    science-based regulation.
  • Premarket deadlines, acute problems, and squeaky
    wheels dominate resource allocation and leave
    programs disconnected and sometimes out of
    balance.
  • Scientific communication opportunities are
    underutilized, whether with scientific peers,
    medical device users or the general public. This
    limits our mission effectiveness.
  • We solve many problems too slowly in a rapidly
    changing world. While decision making is often
    timely, implementation is often not.
  • Peer review is underutilized as a method for
    prioritizing efforts and evaluation. Choices are
    heavily driven by regulatory needs and evaluation
    is usually done through the organizational
    hierarchy.
  • Scientific partnerships with NIH, NAS,
    Universities, professional societies exist, but
    are underdeveloped.

41
Top 10 list of recommendations for
science-based regulation at CDRH
  • CDRH needs to communicate its scientific vision
    and the scientific basis for its regulatory
    actions. It needs advocates for its scientific
    role in medical devices and radiological health,
    including the FDA Science Board.
  • The Center leadership needs to demonstrate the
    priority of science in how it allocates its human
    resources, and through strategies to maintain and
    build science capacity in the Center.
  • CDRH needs to implement the Magnet for Excellence
    goal area of its strategic plan which seeks to
    recruit and retain the type of employees that
    will help us accomplish our public health
    mission.
  • Rich or poor, the Center needs to assure that
    there are enough operating dollars (vs. salary
    dollars) to provide the funds needed to maintain
    the effectiveness of our employees.
  • CDRH needs to identify core competencies and the
    types of experiences that will develop them to
    create a flexible scientific workforce able to
    meet future challenges.
  • The Centers strategic vision of assuring the
    public health throughout the total product life
    cycle and having meaningful measures of the
    impact of our efforts are strategies that will
    allow us to prioritize work better by the impact
    that it has.
  • The goal area of Knowledge Management in the
    Centers strategic plan provides an approach not
    only to the acquisition and management of new
    knowledge, but also to the dissemination to our
    stakeholders to promote our mission.
  • CDRH should set goals, choose important problems,
    assess how to measure impact, create the team
    needed and be accountable for timely results from
    its efforts.
  • Peer review should be routinely incorporated into
    the science-based decision making and
    science-based efforts by peers within and from
    outside the Center to supplement other methods of
    assessing scientific quality and effectiveness.
  • Scientific partnerships with NIH, NAS,
    Universities, professional societies exist,
    should be developed as a source of external
    expertise, as sources of recruitment, and for
    partnerships in mission related activities.
Write a Comment
User Comments (0)
About PowerShow.com